Fractyl Health (GUTS) Depreciation & Amortization (CF) (2023 - 2026)
Fractyl Health (GUTS) reported Depreciation & Amortization (CF) of $281000.0 for Q1 2026, down 3.1% year-on-year from $290000.0 in Q1 2025, and up 12.4% quarter-over-quarter from $250000.0 in Q4 2025.
Fractyl Health (GUTS) has 4 years of Depreciation & Amortization (CF) data on file, last reported at $281000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 3.1% year-over-year to $281000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 19.37% YoY), and the FY2025 full-year result was $1.1 million, up 62.48% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $281000.0, up from $250000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $290000.0 in Q1 2025 and bottomed at $38000.0 in Q4 2023.
- A 4-year average of $180307.7 and a median of $209000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 486.84% in 2024, while the deepest fall reached 33.75% in 2024.
- Tracing GUTS's Depreciation & Amortization (CF) over 4 years: stood at $38000.0 in 2023, then soared by 486.84% to $223000.0 in 2024, then advanced by 12.11% to $250000.0 in 2025, then advanced by 12.4% to $281000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $281000.0, $250000.0, and $290000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 123.20 Mn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 281,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281,000.00 |
| Mar 31, 2026 | 281,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Dec 31, 2025 | 250,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Sep 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Jun 30, 2025 | 270,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Dec 31, 2024 | 223,000.00 |
| Dec 31, 2024 | 223,000.00 |
| Sep 30, 2024 | 209,000.00 |
| Sep 30, 2024 | 209,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Mar 31, 2024 | 53,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 84,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Mar 31, 2023 | 80,000.00 |